(AMTM) Amentum Holdings - Overview
Stock: Engineering, Cybersecurity, Analytics, Environmental, Nuclear
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 50.3% |
| Relative Tail Risk | -15.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.13 |
| Alpha | 46.54 |
| Character TTM | |
|---|---|
| Beta | 1.285 |
| Beta Downside | 1.197 |
| Drawdowns 3y | |
|---|---|
| Max DD | 50.81% |
| CAGR/Max DD | 0.38 |
Description: AMTM Amentum Holdings January 08, 2026
Amentum Holdings, Inc. (NYSE: AMTM) delivers engineering and technology services to U.S. federal agencies and commercial clients through two operating segments: Digital Solutions-covering intelligence analytics, space-system development, cybersecurity and IT-and Global Engineering Solutions, which handles large-scale environmental remediation, nuclear power projects, platform engineering, sustainment and supply-chain management. The firm was incorporated in 2023 and is headquartered in Chantilly, Virginia.
Key quantitative points (based on the most recent FY 2023 filing and industry estimates):
• FY 2023 revenue was approximately $7.6 billion, with the Digital Solutions segment contributing roughly 45 % of total sales.
• The company reported a backlog of about $5.2 billion, indicating a multi-year order pipeline that is roughly 68 % of annual revenue.
• U.S. federal defense and civilian IT spending is projected to grow ~3 % YoY in 2024, a macro driver that supports Amentum’s growth outlook, especially in cyber-security and space services.
Given the firm’s reliance on government contracts, its performance is sensitive to federal budget cycles and geopolitical risk; any significant shift in defense appropriations or environmental remediation funding could materially affect earnings.
For a deeper quantitative view, you may find ValueRay’s platform useful for tracking AMTM’s valuation metrics and peer comparisons.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 66.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 4.33 > 1.0 |
| NWC/Revenue: 5.27% < 20% (prev 14.42%; Δ -9.14% < -1%) |
| CFO/TA 0.05 > 3% & CFO 543.0m > Net Income 66.0m |
| Net Debt (-395.0m) to EBITDA (987.0m): -0.40 < 3 |
| Current Ratio: 1.32 > 1.5 & < 3 |
| Outstanding Shares: last quarter (244.0m) vs 12m ago 0.29% < -2% |
| Gross Margin: 7.18% > 18% (prev 0.08%; Δ 710.4% > 0.5%) |
| Asset Turnover: 122.8% > 50% (prev 64.82%; Δ 58.02% > 0%) |
| Interest Coverage Ratio: 1.33 > 6 (EBITDA TTM 987.0m / Interest Expense TTM 353.0m) |
Altman Z'' 0.51
| A: 0.07 (Total Current Assets 3.11b - Total Current Liabilities 2.35b) / Total Assets 11.46b |
| B: -0.04 (Retained Earnings -461.0m / Total Assets 11.46b) |
| C: 0.04 (EBIT TTM 468.0m / Avg Total Assets 11.72b) |
| D: -0.06 (Book Value of Equity -419.0m / Total Liabilities 6.84b) |
| Altman-Z'' Score: 0.51 = B |
Beneish M -2.71
| DSRI: 0.56 (Receivables 2.48b/2.40b, Revenue 14.39b/7.76b) |
| GMI: 1.11 (GM 7.18% / 8.00%) |
| AQI: 1.01 (AQ_t 0.72 / AQ_t-1 0.71) |
| SGI: 1.85 (Revenue 14.39b / 7.76b) |
| TATA: -0.04 (NI 66.0m - CFO 543.0m) / TA 11.46b) |
| Beneish M-Score: -2.71 (Cap -4..+1) = A |
What is the price of AMTM shares?
Over the past week, the price has changed by +4.89%, over one month by +19.03%, over three months by +72.23% and over the past year by +64.32%.
Is AMTM a buy, sell or hold?
- StrongBuy: 2
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the AMTM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 36.2 | -3.6% |
| Analysts Target Price | 36.2 | -3.6% |
| ValueRay Target Price | 42 | 12% |
AMTM Fundamental Data Overview February 04, 2026
P/E Forward = 15.6006
P/S = 0.6077
P/B = 2.0081
Revenue TTM = 14.39b USD
EBIT TTM = 468.0m USD
EBITDA TTM = 987.0m USD
Long Term Debt = 3.90b USD (from longTermDebt, last quarter)
Short Term Debt = 42.0m USD (from shortTermDebt, last quarter)
Debt = 42.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -395.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.35b USD (8.75b + Debt 42.0m - CCE 437.0m)
Interest Coverage Ratio = 1.33 (Ebit TTM 468.0m / Interest Expense TTM 353.0m)
EV/FCF = 15.38x (Enterprise Value 8.35b / FCF TTM 543.0m)
FCF Yield = 6.50% (FCF TTM 543.0m / Enterprise Value 8.35b)
FCF Margin = 3.77% (FCF TTM 543.0m / Revenue TTM 14.39b)
Net Margin = 0.46% (Net Income TTM 66.0m / Revenue TTM 14.39b)
Gross Margin = 7.18% ((Revenue TTM 14.39b - Cost of Revenue TTM 13.36b) / Revenue TTM)
Gross Margin QoQ = 7.54% (prev 7.02%)
Tobins Q-Ratio = 0.73 (Enterprise Value 8.35b / Total Assets 11.46b)
Interest Expense / Debt = 219.0% (Interest Expense 92.0m / Debt 42.0m)
Taxrate = 48.70% (56.0m / 115.0m)
NOPAT = 240.1m (EBIT 468.0m * (1 - 48.70%))
Current Ratio = 1.32 (Total Current Assets 3.11b / Total Current Liabilities 2.35b)
Debt / Equity = 0.01 (Debt 42.0m / totalStockholderEquity, last quarter 4.50b)
Debt / EBITDA = -0.40 (Net Debt -395.0m / EBITDA 987.0m)
Debt / FCF = -0.73 (Net Debt -395.0m / FCF TTM 543.0m)
Total Stockholder Equity = 4.47b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.56% (Net Income 66.0m / Total Assets 11.46b)
RoE = 1.48% (Net Income TTM 66.0m / Total Stockholder Equity 4.47b)
RoCE = 5.59% (EBIT 468.0m / Capital Employed (Equity 4.47b + L.T.Debt 3.90b))
RoIC = 2.69% (NOPAT 240.1m / Invested Capital 8.91b)
WACC = 10.60% (E(8.75b)/V(8.79b) * Re(10.65%) + (debt cost/tax rate unavailable))
Discount Rate = 10.65% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.14%
[DCF Debug] Terminal Value 59.50% ; FCFF base≈345.3m ; Y1≈226.7m ; Y5≈103.4m
Fair Price DCF = 7.38 (EV 1.40b - Net Debt -395.0m = Equity 1.80b / Shares 243.7m; r=10.60% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -37.79 | EPS CAGR: -90.68% | SUE: -0.92 | # QB: 0
Revenue Correlation: 89.72 | Revenue CAGR: 50.56% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.58 | Chg30d=+0.002 | Revisions Net=+2 | Analysts=10
EPS current Year (2026-09-30): EPS=2.40 | Chg30d=+0.000 | Revisions Net=+4 | Growth EPS=+8.1% | Growth Revenue=-1.4%
EPS next Year (2027-09-30): EPS=2.75 | Chg30d=+0.015 | Revisions Net=+4 | Growth EPS=+14.5% | Growth Revenue=+3.9%